stars 1 stars 2 stars 3

BioClone Ltd. is a global organisation bringing together biopharmaceutical companies for the development, production and approval of future biologically based drugs and delivery devices. Based in London we provide training, consulting and project management services as well as access to international expertise in biotechnological analysis, transport, cell banking and production throughout development, pre-clinical to clinical trials and pharmacovigilance. In addition we assist in developing specifications and procedures to meet the regulatory requirements and gain approval from statutory regulatory authorities including the EMA, FDA and DRA. CONNECT PROMOTE SUCCEED

BioClone Ltd. Questions

The BioClone Ltd. annual revenue was $1.4 million in 2026.

Andrew Kenyon is the CEO of BioClone Ltd..

2 people are employed at BioClone Ltd..

Top BioClone Ltd. Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users